8-[(3-methyl-2-pyridinyl)methyl]-1-oxo-2-(4-phenylphenyl)-2,8-diazaspiro[4.5]decane-3-carboxylic acid
C28H29N3O3 — CID 57386521
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-[(3-methyl-2-pyridinyl)methyl]-1-oxo-2-(4-phenylphenyl)-2,8-diazaspiro[4.5]decane-3-carboxylic acid
8-[(3-methyl-2-pyridinyl)methyl]-1-oxo-2-(4-phenylphenyl)-2,8-diazaspiro[4.5]decane-3-carboxylic acid (PubChem CID 57386521) has the molecular formula C28H29N3O3 and a molecular weight of 455.56 g/mol. Its IUPAC name is 8-[(3-methyl-2-pyridinyl)methyl]-1-oxo-2-(4-phenylphenyl)-2,8-diazaspiro[4.5]decane-3-carboxylic acid.
Molecular Properties
| Compound Name | 8-[(3-methyl-2-pyridinyl)methyl]-1-oxo-2-(4-phenylphenyl)-2,8-diazaspiro[4.5]decane-3-carboxylic acid |
|---|---|
| PubChem CID | 57386521 |
| Molecular Formula | C28H29N3O3 |
| Molecular Weight | 455.56 g/mol |
| Exact Mass | 455.22 |
| IUPAC Name | 8-[(3-methyl-2-pyridinyl)methyl]-1-oxo-2-(4-phenylphenyl)-2,8-diazaspiro[4.5]decane-3-carboxylic acid |
| SMILES | Cc1cccnc1CN1CCC2(CC1)CC(C(=O)O)N(c1ccc(-c3ccccc3)cc1)C2=O |
| InChI | InChI=1S/C28H29N3O3/c1-20-6-5-15-29-24(20)19-30-16-13-28(14-17-30)18-25(26(32)33)31(27(28)34)23-11-9-22(10-12-23)21-7-3-2-4-8-21/h2-12,15,25H,13-14,16-19H2,1H3,(H,32,33) |
| InChIKey | PBPNZBHJJCGTEK-UHFFFAOYSA-N |
| XLogP | 4.53 |
| TPSA | 73.74 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 455.56 |
| LogP ≤ 5 | 4.53 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 57386521 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.